High Tower Advisors, LLC Cue Biopharma, Inc. Transaction History
High Tower Advisors, LLC
- $71.3 Billion
- Q1 2025
A detailed history of High Tower Advisors, LLC transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 128,284 shares of CUE stock, worth $89,798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128,284
Previous 128,284
-0.0%
Holding current value
$89,798
Previous $132,000
12.12%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CUE
# of Institutions
52Shares Held
11.5MCall Options Held
10.1KPut Options Held
1.4K-
Bleichroeder LP New York, NY5MShares$3.5 Million1.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$1.62 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$529,7150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA694KShares$485,7220.0% of portfolio
-
Robertson Stephens Wealth Management, LLC San Francisco, CA479KShares$334,9500.02% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $24.8M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...